PRO-DEX, INC. (PDEX) Quick Ratio
- Quick ratio · latest quarter: Value 2.35×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 2.35× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $30.55M ÷ $12.98M ≈ 2.35× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 30.55M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 12.98M USD | Liabilities, Current |
| Cash and equivalents | 8.19M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 1.15M USD | Marketable Securities, Current |
| Customer receivables | 21.20M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 21.46M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.55M | $12.98M | $8.19M | $1.15M | $21.20M | $21.46M | 2.35× |
| 2026-03-31 | $27.09M | $14.64M | $6.63M | $986.00K | $19.47M | $22.36M | 1.85× |
| 2025-12-31 | $24.02M | $12.20M | $5.27M | $864.00K | $17.88M | $21.71M | 1.97× |
| 2025-09-30 | $28.30M | $13.60M | $33.00K | $10.04M | $18.23M | $21.56M | 2.08× |
| 2025-06-30 | $23.59M | $14.63M | $419.00K | $6.74M | $16.43M | $22.21M | 1.61× |
| 2025-03-31 | $21.31M | $18.32M | $33.00K | $5.42M | $15.86M | $23.43M | 1.16× |
| 2024-12-31 | $23.20M | $17.14M | $66.00K | $4.67M | $18.47M | $19.61M | 1.35× |
| 2024-09-30 | $21.27M | $11.29M | $3.08M | $4.74M | $13.46M | $16.60M | 1.89× |
| 2024-06-30 | $20.73M | $12.89M | $2.63M | $4.22M | $13.89M | $15.27M | 1.61× |
| 2024-03-31 | $16.73M | $10.42M | $3.22M | $1.00M | $12.52M | $14.24M | 1.61× |
| 2023-12-31 | $15.22M | $9.99M | $1.29M | $763.00K | $13.17M | $15.03M | 1.52× |
| 2023-09-30 | $13.95M | $8.28M | $1.90M | $1.01M | $11.03M | $16.26M | 1.68× |
| 2023-06-30 | $14.02M | $9.68M | $2.94M | $1.13M | $9.95M | $16.17M | 1.45× |
| 2023-03-31 | (m) | $10.14M | $2.09M | (m) | $10.56M | $15.14M | (m) |
| 2022-12-31 | (m) | $11.66M | $382.00K | (m) | $12.20M | $15.13M | (m) |
| 2022-09-30 | (m) | $11.67M | $2.80M | (m) | $11.04M | $15.66M | (m) |
| 2022-06-30 | (m) | $11.35M | $849.00K | (m) | $15.38M | $12.68M | (m) |
| 2022-03-31 | $14.57M | $7.72M | $4.76M | $1.13M | $8.68M | $11.87M | 1.89× |
| 2021-12-31 | $15.34M | $5.97M | $5.25M | $1.24M | $8.85M | $9.29M | 2.57× |
| 2021-09-30 | $16.78M | $6.21M | $5.18M | $1.51M | $10.09M | $8.91M | 2.70× |
| 2021-06-30 | (m) | $5.87M | $3.72M | (m) | $10.93M | $8.44M | (m) |
| 2021-03-31 | $16.92M | $6.48M | $3.87M | $1.12M | $11.92M | $8.37M | 2.61× |
| 2020-12-31 | $13.03M | $4.93M | $5.52M | $2.88M | $4.62M | $9.15M | 2.64× |
| 2020-09-30 | $13.74M | $4.45M | $5.20M | $2.40M | $6.14M | $8.31M | 3.09× |
| 2020-06-30 | (m) | $5.23M | $6.42M | (m) | $5.16M | $8.24M | (m) |
| 2020-03-31 | $11.32M | $4.44M | $4.38M | $2.77M | $4.17M | $8.64M | 2.55× |
| 2019-12-31 | $12.40M | $3.95M | $6.17M | $3.54M | $2.68M | $7.81M | 3.14× |
| 2019-09-30 | $12.79M | $3.55M | $6.50M | $3.13M | $3.16M | $6.84M | 3.61× |
| 2019-06-30 | (m) | $4.27M | $7.74M | (m) | $4.10M | $6.24M | (m) |
| 2019-03-31 | $16.22M | $3.75M | $9.66M | $2.81M | $3.74M | $4.80M | 4.32× |
| 2018-12-31 | (m) | $2.67M | $8.87M | (m) | $3.81M | $4.54M | (m) |
| 2018-09-30 | (m) | $2.90M | $8.31M | (m) | $3.62M | $4.57M | (m) |
| 2018-06-30 | (m) | $2.54M | $5.19M | (m) | $2.96M | $4.39M | (m) |
| 2018-03-31 | (m) | $1.96M | $5.10M | (m) | $3.43M | $3.38M | (m) |
| 2017-12-31 | (m) | $1.97M | $5.26M | (m) | $3.15M | $3.20M | (m) |
| 2017-09-30 | (m) | $1.79M | $5.86M | (m) | $2.25M | $3.51M | (m) |
| 2017-06-30 | (m) | $2.58M | $4.21M | (m) | $3.54M | $3.08M | (m) |
| 2017-03-31 | (m) | $2.35M | $3.70M | (m) | $3.88M | $2.98M | (m) |
| 2016-12-31 | (m) | $2.72M | $2.18M | (m) | $1.03M | $3.27M | (m) |
| 2016-09-30 | (m) | $2.65M | $2.17M | (m) | $1.54M | $3.37M | (m) |
| 2016-06-30 | (m) | $2.08M | $2.29M | (m) | $1.47M | $3.57M | (m) |
| 2016-03-31 | (m) | $2.17M | $1.45M | (m) | $2.17M | $4.12M | (m) |
| 2015-12-31 | (m) | $3.13M | $1.05M | (m) | $1.83M | $4.48M | (m) |
| 2015-09-30 | (m) | $3.61M | $493.00K | (m) | $759.00K | $4.25M | (m) |
| 2015-06-30 | (m) | $3.69M | $697.00K | (m) | $2.33M | $4.31M | (m) |
| 2015-03-31 | (m) | $3.78M | $1.48M | (m) | $2.10M | $3.44M | (m) |
| 2014-12-31 | (m) | $2.69M | $1.97M | (m) | $1.11M | $2.88M | (m) |
| 2014-09-30 | (m) | $2.13M | $3.61M | (m) | $1.09M | $2.59M | (m) |
| 2014-06-30 | (m) | $2.13M | $3.19M | (m) | $1.78M | $2.60M | (m) |
| 2014-03-31 | (m) | $2.21M | $1.93M | (m) | $1.10M | $3.18M | (m) |
| 2013-12-31 | (m) | $2.02M | $1.55M | (m) | $1.58M | $3.55M | (m) |
| 2013-09-30 | (m) | $1.89M | $1.83M | (m) | $1.36M | $3.97M | (m) |
| 2013-06-30 | (m) | $2.31M | $1.68M | (m) | $1.34M | $3.83M | (m) |
| 2013-03-31 | (m) | $2.25M | $2.04M | (m) | $1.58M | $3.75M | (m) |
| 2012-12-31 | (m) | $1.63M | $2.55M | (m) | $1.18M | $3.52M | (m) |
| 2012-09-30 | (m) | $2.62M | $3.13M | (m) | $1.84M | $3.48M | (m) |
| 2012-06-30 | (m) | $2.88M | $4.11M | (m) | $1.58M | $2.79M | (m) |
| 2012-03-31 | (m) | $3.38M | $4.88M | (m) | $2.23M | $3.06M | (m) |
| 2011-12-31 | (m) | $3.75M | $4.27M | (m) | $2.25M | $4.73M | (m) |
| 2011-09-30 | (m) | $3.40M | $4.91M | (m) | $2.33M | $4.04M | (m) |
| 2011-06-30 | (m) | $4.02M | $4.69M | (m) | $3.13M | $3.70M | (m) |
| 2011-03-31 | (m) | (m) | $3.78M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $2.02M | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $2.54M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.79M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |